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Simple Summary: Artificial intelligence techniques were used for the detection of prostate cancer
through tissue feature engineering. A radiomic method was used to extract the important features
or information from histopathology tissue images to perform binary classification (i.e., benign vs.
malignant). This method can identify a histological pattern that is invisible to the human eye, which
helps researchers to predict and detect prostate cancer. We used different performance metrics to
evaluate the results of the classification. In the future, it is expected that a method like radiomic will
provide a consistent contribution to analyze histopathology tissue images and differentiate between
cancerous and noncancerous tumors.
Abstract: The optimal diagnostic and treatment strategies for prostate cancer (PCa) are constantly
changing. Given the importance of accurate diagnosis, texture analysis of stained prostate tissues
is important for automatic PCa detection. We used artificial intelligence (AI) techniques to classify
dual-channel tissue features extracted from Hematoxylin and Eosin (H&E) tissue images, respectively.
Tissue feature engineering was performed to extract first-order statistic (FOS)-based textural features
from each stained channel, and cancer classification between benign and malignant was carried out
based on important features. Recursive feature elimination (RFE) and one-way analysis of variance
(ANOVA) methods were used to identify significant features, which provided the best five features
out of the extracted six features. The AI techniques used in this study for binary classification
(benign vs. malignant and low-grade vs. high-grade) were support vector machine (SVM), logistic
regression (LR), bagging tree, boosting tree, and dual-channel bidirectional long short-term memory
(DC-BiLSTM) network. Further, a comparative analysis was carried out between the AI algorithms.
Two different datasets were used for PCa classification. Out of these, the first dataset (private) was
used for training and testing the AI models and the second dataset (public) was used only for testing
to evaluate model performance. The automatic AI classification system performed well and showed
satisfactory results according to the hypothesis of this study.
Keywords: artificial intelligence; tissue feature engineering; dual-channel; prostate cancer; texture
analysis; binary classification; prostate cancer detection
1. Introduction
In 2011, the World Health Organization (WHO) reported that cancer caused more
deaths than strokes and coronary heart disease combined, and global demographics and
epidemiological indications suggested that the trend would continue, especially in low-
income countries. Annual cancer cases may exceed 20 million as early as 2025. In 2012,
14.1 million new cancer patients and 8.2 million cancer deaths occurred worldwide; lung,
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breast, colon, prostate, stomach and liver cancers accounted for 55% of the global burden.
Prostate cancer (PCa) is common (1.1 million cases and 307,000 deaths annually) and
confined to males [1,2]. Although optimal PCa diagnosis and treatment change constantly,
the Gleason grading system is a good predictor.
PCa stages are defined by the Gleason score and the tumor (T) score. The Gleason
score, which ranges from 1 to 5, reflects tumor aggressiveness. The Gleason grading system
is used if a biopsy finds cancer, which recognizes five stages of PCa according to gland
shape and extent of differentiation [3,4]. Pathologists grade PCa based on the primary and
secondary Gleason scores. The primary and secondary scores reflect the three factors used
to grade cancer. On the other hand, the stages of PCa using the T score are measured by
rating the size and extent of the original tumor. Here, the PCa is grouped into four stages
(i.e., T1 to T4). Figure 1a,b shows the grading and staging of PCa.
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of observed cells ay be tu orous. I prove ents in diagnosis and more targeted treat-
ents are needed [5,6]. n I syste ay be helpful. Recently, eep ind (Google) has
dra atically reduced breast cancer diagnosis error [7]. Novartis is working with PathAI to
develop AI for cancer diagnosis and treatment decision-making [8].
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To perform cancer analysis and classification, machine learning (ML) is an appropriate
method compared to visual analysis. The main difference between deep learning (DL)
and ML classification is the way data is presented to the system. ML algorithms require
organized data, while DL relies on layers of artificial neural networks (ANN). Generally, DL
requires a large amount of data for better prediction and more computational time, whereas
ML can predict accurately even with a small dataset and requires less computational time.
Our study focuses on a texture feature-based classification using AI techniques. There are
many tools provided by ML by which data can be analyzed and classified automatically.
Tissue images contain a lot of information (i.e., grey level patterns), which are difficult
to analyze by eye because of the invisibility [9]. This textural information can be extracted
and analyzed using a radiomics technique [10] and through the process of tissue feature
engineering (i.e., the computation of tissue-level features). Feature selection optimally
reduces computational complexity and improves classification accuracy and model perfor-
mance. Features are the 2D spatial values of an image that represents the type of texture.
In this paper, the recursive feature elimination (RFE) method was used to select the best
features for AI classification. This method is popular and easy to configure because it is
highly effective at selecting significant features in the dataset. Further, an ANOVA test was
performed to identify the significant difference between benign and malignant features.
The texture is a key element of human-recognizable visual perception and is used
in various ways in computer vision systems. It is easy for the human eye to distinguish
different textures, but this can be perceived as a rather tricky problem on a computer.
Among the techniques for analyzing textures, a structural approach is used for the statistical
characteristics of images because the pattern of textures creates the structure, and the
texture has different consistent properties. Statistical analysis methods indirectly express
textures by nondecisive attributes that control the distribution and relationship between the
intensity levels of the image. Accurate diagnoses and cancer grading are essential. Grade-
specific features must be defined. Here, we use a feature extraction process called feature
engineering to extract textural aspects from tissue images and differentiate malignant
(grade 3, 4, and 5) from benign (grade 1 and 2) and grade 5 from grade 3 prostatic samples
using the proposed AI models, which include support vector machine (SVM), logistic
regression (LR), boosting tree, bagging tree, and dual-channel bidirectional long short-term
memory (DC-BiLSTM). Pixel distribution analysis is very important to understand the
variation of intensity in the image.
2. Related Work
Existing research on tissue texture analysis and classification has shown promising
performance for PCa detection using Hematoxylin and Eosin (H&E) histopathology images.
Most of the existing research focuses on binary classification for differentiating malignant
and benign tumors using computer-aided diagnosis (CAD) tools. In the past, many re-
searchers used an AI system to detect malignant biopsies and decrease the workload of
pathologists. Therefore, the pathologist can be assisted through an AI system with the
detection of PCa among the biopsies that are included in the preliminary screening process.
In this section, we mainly discuss the methods of classification and feature extraction. Past
studies related to AI-based classification are summarized in Table 1.
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Table 1. Past studies related to cancer detection using artificial intelligence (AI) techniques.






(benign vs. malignant) GLCM and GLRLM features
The association rule method was used for image classification. Accuracies of 94.9%
and 92.3% were achieved using all and significant features, respectively.
Neeta et al.,
2015 [12] SVM and K-NN
Binary
(benign vs. malignant) GLDM and Gabor features
Detection of PCa using CAD algorithm and the best result of 95.83% was achieved




(benign vs. malignant) GLCM and GLRLM features
Breast cancer diagnosis was performed by classifying the texture features based on
GLCM and GLRLM extracted from the segmented nuclei. The best result of 90% was
obtained by combining the optimal features of GLRLM.
Radhakrishnan





TRUS medical images were used for prostate cancer classification. The DBSCAN
clustering method was used for extracting the prostate region. The best accuracy of







Image texture based on
Gauss-Markov random field, Fourier
transform, stationary wavelets
Prostate tissue images of 80 benign and 80 malignant cell nuclei were evaluated. The




(benign vs. malignant) Color moment and GLCM features
Wavelet-based GLCM and color moment descriptor were extracted from prostate tissue




(cancer vs. non-cancer) MRI scans
PCa and noncancerous tissues were distinguished using DCNN. An AUC of 0.944, a
sensitivity of 87.0%, a specificity of 90.6 PPV of 87.0%, and an NPV of 90.6% were
achieved using DCNN.
Bhattacharjee
et al., 2019 [18] SVM
Binary (benign vs. malignant) and Multiclass
(benign vs. grade 3 vs. grade 4 vs. grade 5) Morphological features
Morphological feature classification was performed for discriminating benign from
malignant tumor, grade 3 from grade 4, 5 tumors, and grade 4 from grade 5 tumor. The





GLCM, Gray-level histogram, and
general features
T2-weighted prostate MRI scans were used to extract 12 different types of features.
Feature classification was performed using an artificial neural network. For PZ and
CG, the accuracies achieved using a CAD system were 80.3% and 84.0%, respectively.
Roy et al.,
2019 [20] CNN
Binary (nonmalignant vs. malignant) and
Multiclass (normal vs. benign vs. in situ vs.
invasive carcinoma)
Histology images
The patch-based classifier using CNN was developed for the automated classification
of histopathology images. In classifying the images of the cancer histology test dataset,
the proposed technique achieved promising accuracies for both binary and
multiclass classification.
Chakraborty
et al., 2020 [21] DCRCNN
Binary
(cancer vs. noncancer) Histopathologic scans
A dual-channel residual convolution neural network was used to classify the tissue
images of the lymph node section. The model was trained with 220,025 images and
achieved an overall accuracy of 96.47%.
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The studies in Table 1 show that different AI techniques and parameters have been
used for cancer classification. Most of the studies performed binary classification using
second-order statistical features to discriminate between noncancerous and cancerous
tumors. Among them, Chakraborty et al. [21] achieved the best result in classifying the
histopathologic scans of the lymph node section using a dual-channel residual convolution
neural network. Similarly, the present study achieved astounding results in classifying
the first-order statistic (FOS)-based texture features extracted from H&E channels, and
considering all these different approaches, a comparative analysis was performed using
the various AI models, namely SVM, LR, bagging tree, boosting tree, and DC-BiLSTM.
3. Data Collection and Image Representation
3.1. Data Collection
The following two datasets were collected from two different centers. Out of these, one
was private and the other one was public. Both the datasets were used for preprocessing,
prior to feature extraction and classification.
Private Dataset: The tissue slides used for this research were acquired from 20 patients
and prepared at the Severance Hospital of Yonsei University, Korea. To prepare the tissue
slides, the pathologist used the H&E staining system. Deparaffinization and rehydration
were performed before H&E staining, as incomplete removal of paraffin wax compromises
staining. Tissues were sectioned to 4 µm and autostained. Slides were scanned at 40× magni-
fication using a 0.3-NA objective (Olympus BX-51 microscope) and photographed (Olympus
C-3000 digital camera). Each slide contained 33,584 × 70,352 pixels. H&E-stained regions
of interest (ROIs) of 256 × 256 pixels were extracted from whole slide images (WSIs), as
shown in Figure 2. As shown in Table 2, 500 images were used for textural analysis, feature
extraction, and classification, of which 250 were benign and 250 malignant (50 of grade 3,
100 of grade 4, and 100 of grade 5).




Figure 2. Microscopic biopsy images of a private dataset at the magnification factor of 40×. (a) Be-
nign tumor. (b) Grade 3 tumor. (c) Grade 4 tumor. (d) Grade 5 tumor. 
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External Test Set: The dataset was collected online and publicly available at 
https://zenodo.org/record/1485967#.X_0ue-gzZMs (accessed on 25 January 2021). Bulten 
et al. [22] made their dataset and uploaded it to the Zenodo repository, which can be used 
for external validation. A total of 102 patients experienced a radical prostatectomy at the 
Medical Center of Radboud University. Out of these, the H&E-stained samples of 40 pa-
tients were selected to check the performance of the models, of which the WSI for each 
patient was divided into four sections (i.e., two containing benign epithelium and two 
containing tumor). From each section, the ROIs of 2500 × 2500 pixels were extracted at 10× 
magnification, shown in Figure 3. As a result, 160 ROIs were extracted (89 of benign epi-
thelial and 71 of tumor). The best 10 ROIs of benign epithelial and tumor were selected 
for model validation. 
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3.2. Image Representation 
A power-law transformation (gamma correction) [23,24] was applied to the private 
dataset to adjust the contrast level of the tissue image. This method controls the overall 
brightness of an image and therefore, helps to display it accurately on a computer screen. 
Further, the preprocessed ROIs of H&E tissue samples (i.e., private dataset and external 
test set) were used for generating the non-overlapping patches of size 64 × 64 pixels, and 
a stain deconvolution technique was used to separate the Hematoxylin and Eosin chan-
nels from the extracted patches, as shown in Figure 4. A total of 8000 patches were selected 
from each dataset (private and external). Before generating patches of the external test set, 
the ROIs were resized to 2048 × 2048 pixels. According to the rule of thumb, the greater 
the learning samples per class [25], the better the model classification. Patch-based texture 
Figure 2. icroscopic biopsy images of a private dataset at the magnification factor of 40×. (a) Benign
tumor. (b) Grade 3 tumor. (c) Grade 4 tumor. (d) Grade 5 tumor.
Table 2. The numbers of benign and malignant images used for training and testing. Private dataset
structure at 40× magnification factor.
Groups Training Testing Total
Train Validation
Benign 160 40 50 250
Malignant 160 40 50 250
Total 320 80 100 500
External Test Set: The dataset was collected online and publicly available at https://
zenodo.org/record/1485967#.X_0ue-gzZMs (accessed on 25 January 2021). Bulten et al. [22]
made their dataset and uploaded it to the Zenodo repository, which can be used for external
validation. A total of 102 patients experienced a radical prostatectomy at the Medical Center
of Radboud University. Out of these, the H&E-stained samples of 40 patients were selected
to check the performance of the models, of which the WSI for each patient was divided
into four sections (i.e., two containing benign epithelium and two containing tumor). From
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each section, the ROIs of 2500 × 2500 pixels were extracted at 10× magnification, shown in
Figure 3. As a result, 160 ROIs were extracted (89 of benign epithelial and 71 of tumor).
The best 10 ROIs of benign epithelial and tumor were selected for model validation.
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Figure 3. Microscopic biopsy i ages of an external test set at t e a ificati f ct r f . (a,b)
Benign tumor. (c,d) Malignant tumor.
3.2. Image Representation
A power-law transformation (ga a correction) [23,24] was applied to the private
dataset to adjust the contrast level of the tissue image. This method controls the overall
brightness of an image and therefore, helps to display it accurately on a computer screen.
Further, the preprocessed ROIs of H&E tissue samples (i.e., private dataset and external
test set) were used for generating the non-overlapping patches of size 64 × 64 pixels, and a
stain deconvolution technique was used to separate the Hematoxylin and Eosin channels
from the extracted patches, as shown in Figure 4. A total of 8000 patches were selected
from each dataset (private and external). Before generating patches of the external test set,
the ROIs were resized to 2048 × 2048 pixels. According to the rule of thumb, the greater
the learning samples per class [25], the better the model classification. Patch-based texture
analysis was performed to increase the number of samples in the dataset and to extract
more discriminating features.
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4. Materials and Methods
The proposed pipeline of this study is depicted in Figure 5. First, after ROIs (256 × 256
pixels) acquisition from the stained WSI, the images were separated between two groups
(benign and malignant). Second, the extracted ROIs were used for patch generation,
gamma correction, and stain deconvolution. Third, for texture analysis, a set of radiomic
features were extracted from dual-channel (Hematoxylin and Eosin) separately. Forth,
two steps of feature selection (RFE and one-way ANOVA) were carried out to validate
feature significance. Fifth, a binary classification was performed using the AI models.
Finally, a comparative analysis of classification algorithms and performance evaluation
was performed using a confusion matrix and receiver operating characteristic (ROC) curve.
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4.1. Patch-Based Feature Engineering
The textural analysis exploits spatial changes in image patterns to extract information
from both images and shapes. Such features are effective classifiers because they contain
statistical data on adjacent pixels in images [26,27]. Here, we extracted image textural
features and classified them using AI-based models. Radiomic is a technique of extracting
a large number of features from captured visual content of medical images for analysis and
classification. In this paper, we extracted FOS-based features in which the texture values
were statistically computed from an individual pixel without considering the relationships
of neighboring pixels [28]. The given radiomic features [29] that were extracted from H&E
staining channels are given in the Supplementary Information (SI), Feature Extraction, and
Table S1.
4.2. Features Selection
To select significant features from those extracted, we used two-step feature selection
methods, namely wrapper (RFE) [30] and filter (one-way ANOVA) [31]. At times, due to
insignificant input features, the learning algorithms could be deceived, resulting in poor
predictive performance. Therefore, feature selection is an important step for AI-based
classification, which selects the most relevant features for a dataset.
First, the best five features were selected using an RFE (greedy optimization algorithm)
technique, which generates baseline models repeatedly and selects the strongest or weakest
performing feature at each iteration until all the features are classified. In our study, a
gradient boosting classifier was used as a baseline model to carry out the RFE process [32].
As a result, features were ranked based on the descending order from strongest to weakest,
as shown in Figure 6.
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where SSeffect is the sum of squares between the groups, SStotal is the sum of squares
between + within the groups, and η2 is the eta squared.
Table 3. The second step feature selection using one-way ANOVA. Significant features are identified
based on p-value < 0.05, and large effect size.
Feature Name
Significance Effect Size
F-Value p-Value Eta Squared
Energy 25,550.5 <0.05 0.77127
Skewness 3375.6 <0.05 0.32936
Kurtosis 2351.6 <0.05 0.35199
Entropy 5742.8 <0.05 0.58838
Variance 5689.3 <0.05 0.58672
4.3. Binary Classification
The classification of textural features from medical images provides useful information
and helps pathologists to make accurate decisions. In this paper, we used AI-based algo-
rithms to perform binary classification and differentiate malignant from benign tissue and
high-grade (grade 5) from low-grade (grade 3) tissue samples. ML and DL-based classifica-
tion are very important to understand the image patterns of a certain disease. To perform
the ML classification, extracted features from H&E are concatenated before initiating the
learning process. In contrast, for DL-based DC-BiLSTM classification, the dual-channel
features from H&E are concatenated through the learning process. In this work, multiple
ML and DL-based algorithms were developed, and we carried out a comparative analysis
to determine performance based on the evaluation metrics. A detailed explanation of the
classification methods is given in the Supplementary Information (SI) and Classification Al-
gorithms [35–45]. In the Supplementary Information, Figures S1–S3 show the classification
process of Bagging and Boosting and LSTM algorithms, respectively.
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In this paper, we proposed a DC-BiLSTM model for learning dual-channel tissue
features and discriminating diseases based on normal and abnormal prostate tissues, which
is a novel approach. In general, a unidirectional LSTM model consists of one LSTM that
works only in one way, learning the input features from the past to the future in a forward
direction. On the other hand, a BiLSTM [46] model consists of two LSTMs that work in
two ways, one learning the inputs from past to future and the other from future to past in a
forward and backward direction. In BiLSTM, the information learned from both directions
is concatenated for the final computation. As shown in Figure 7, DC-BiLSTM network
consisted of two input channels for learning Hematoxylin and Eosin-based tissue features.
Two layers of BiLSTM were used for each input channel containing the same number of
nodes (i.e., time steps and cells = 64). The model concatenated the outputs of the two
channels into a single feature vector and passed them to a fully connected layer for cancer
classification.
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The hypothesis we created for the binary classification is as follows: 
i r . str ct r f t r s - i t r .
fi ti i f ll :
(a) For the internal test set, the recall of benign vs. malignant and grade 3 vs. grade 5
classification must be ≥90% and ≥80%, respectively.
(b) For the external test set, the recall of benign vs. malignant classification must be ≥85%.
5. Experimental Results
5.1. Model Performance
The implementation (i.e., image representation, feature extraction, feature selection,
model classification) for this study was carried out using MATLAB and Python program-
ming on an Intel Core i7 workstation with 24 GB RAM. For the analysis and classification
of dual-channel tissue features, we used both private and public datasets. For the private
dataset of benign and malignant tissue, we extracted 8000 patches from 500 ROIs of size
256 × 256 pixels. Out of these, 5120 were for training, 1280 for validation, and 1600 for
testing. Moreover, within the malignant tissues, 1600 patches were extracted separately
from 100 ROIs (50 of grade 3 and 50 of grade 5) to validate the performance of the trained
classifiers in distinguishing between low-grade and high-grade disease. On the other hand,
for the external test set, we extracted 10,240 patches from 10 ROIs of size 2048 × 2048 pixels,
of which the best 8000 patches, excluding background, were selected for model validation
in distinguishing between benign and malignant tissues. The evaluation metrics used to
compute the results of binary classification were accuracy, recall, precision, and f1-score.
Tables 4–6 show the test results and comparative analysis of the multiple learning algo-
rithms for the private and public datasets. For the internal test sets of benign vs. malignant
and grade 3 vs. grade 5, the best classification results obtained by DC-BiLSTM were ac-
curacy = 98.6% and 93.5%, precision = 98.2% and 96.3%, recall = 98.9% and 91.2%, and F1
score = 98.6% and 93.7%, respectively. For the external test set of benign vs. malignant, the
best classification results obtained by Boosting Tree were accuracy = 93.5%, precision =
92.9%, recall = 94.1%, and F1 score = 93.5%.
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Table 4. Comparative analysis of the performance of multiple classifiers in distinguishing between
benign and malignant tissue. The performance metrics are for the internal test dataset.
Models Accuracy Precision Recall F1-Score
SVM 96.1% 95.3% 96.9% 96.1%
LR 96.1% 95.5% 96.8% 96.1%
Bagging Tree 95.6% 95.0% 96.2% 95.6%
Boosting Tree 96.0% 95.5% 96.4% 95.9%
DC-BiLSTM 98.6% 98.2% 98.9% 98.6%
Table 5. Comparative analysis of the performance of multiple classifiers in distinguishing between
low-grade and high-grade disease. The performance metrics are for the internal test dataset.
Models Accuracy Precision Recall F1-Score
SVM 85.2% 89.5% 82.4% 85.8%
LR 85.1% 89.5% 89.2% 85.7%
Bagging Tree 80.8% 80.8% 80.8% 80.8%
Boosting Tree 86.0% 84.7% 86.9% 85.8%
DC-BiLSTM 93.6% 96.3% 91.2% 93.7%
Table 6. Comparative analysis of the performance of multiple classifiers in distinguishing between
benign and malignant tissue. The performance metrics are for the external test dataset.
Models Accuracy Precision Recall F1-Score
SVM 88.2% 83.1% 92.6% 87.6%
LR 87.9% 82.2% 92.1% 87.3%
Bagging Tree 91.3% 87.5% 94.7% 91.0%
Boosting Tree 93.5% 92.9% 94.1% 93.5%
DC-BiLSTM 89.2% 88.7% 90.0% 89.2%
5.2. Result Evaluation
It was found from the comparative analysis that DC-BiLSTM and Boosting tree outper-
formed all the other classifiers. In general, for evaluating the performance of the classifi-
cation model, the N × N confusion matrix is used which compares the target labels with
those predicted by the models. Therefore, we used 2 × 2 matrices for evaluating the results
of binary classification. Tables 7–9 show confusion matrices for the internal and external
test sets with magnification factors of 40× and 10×, respectively. In classifying benign and
malignant tissue, the confusion matrix of each classifier demonstrated that the malignant
samples were more accurately classified compared to benign samples. This is because the
tissue texture between malignant and benign samples was very different from each other.
However, in the malignant dataset, low-grade samples were also included whose texture
pattern was fairly similar to benign. Consequently, the classifier identified some of the
low-grade samples as benign and the misclassification rate of benign increased gradually.
Table 7. Confusion matrices of classification algorithms—Malignant vs. Benign (internal test set).
Binary
Classification
SVM LR Bagging Tree
Benign Malignant Benign Malignant Benign Malignant
Benign 763 37 764 36 760 40
Malignant 24 776 25 775 30 770
Boosting Tree DC-BiLSTM
Benign Malignant Benign Malignant
Benign 764 36 786 14
Malignant 28 772 8 792
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Table 8. Confusion matrices of classification algorithms—Grade 3 vs. Grade 5 (internal test set).
Binary
Classification
SVM LR Bagging Tree
Grade 3 Grade 5 Grade 3 Grade 5 Grade 3 Grade 5
Grade 3 716 84 716 84 647 153
Grade 5 153 647 155 645 153 647
Boosting Tree DC-BiLSTM
Grade 3 Grade 5 Grade 3 Grade 5
Grade 3 678 122 771 29
Grade 5 102 698 74 726
Table 9. Confusion matrices of classification algorithms—Malignant vs. Benign (external test set).
Binary
Classification
SVM LR Bagging Tree
Benign Malignant Benign Malignant Benign Malignant
Benign 3327 673 3318 682 3503 497
Malignant 266 3734 283 3717 195 3805
Boosting Tree DC-BiLSTM
Benign Malignant Benign Malignant
Benign 3719 281 3550 450
Malignant 233 3767 409 3591
Figure 8 shows the receiver operating characteristic (ROC) curve and area under
the ROC curve (AUC), which was generated to measure and compare the usefulness of
the optimum AI models. AUCs of 1.00, 0.98, and 0.95 were achieved by the AI system
representing the ability to distinguish malignant from benign and grade 5 from grade 3
tissue samples.
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. iscussion
We developed an AI-based CAD system for PCa classification that can achieve out-
standing discrimination between benign and malignant biopsy tissue samples. This system
can classify only binary samples for cancer detection. The initial step of this work was to
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analyze the ROIs of benign, grade 3, grade 4 and grade 5 tissue samples. We used QuPath
open-source software for analyzing the tissue samples manually and separated the ROIs into
two classes, namely benign and malignant (i.e., grade 3, grade 4, and grade 5). In benign
samples, the glands are small and uniform in shape, with more stroma between glands,
whereas in malignant samples, there are irregular masses of neoplastic glands, absence of
glands and sheets of cells. Tissue-level texture analysis was performed for differentiating
malignant from benign tumors and grade 5 from grade 3 tumors. In general, we analyzed
the image texture by calculating the magnitude of the pixel values, peaks of the distribution
values, randomness in the image values, homogeneity of the image intensity values, the
coarseness of image texture, gray level intensity and a grouping of pixels with similar values.
Before we performed feature extraction, selection, and classification, we generated
small patches of size 64 × 64 pixels from the selected ROIs and used the stain deconvolution
method to separate the H&E channels. FOS-based features (energy, entropy, kurtosis,
skewness, variance and uniformity) were calculated from each staining channel separately.
Out of six extracted features, the best five were selected using RFE and a one-way ANOVA
technique based on the feature ranking, p-values and effect size (eta squared). Later, the
significant features of the two channels (H&E) were concatenated and classified using
the AI models. Although the external test set was unknown for the learning models, the
AI system performed well in the binary classification. The bar charts of the comparative
analysis are given in the Supplementary Information (SI) and Figures (Figure S4a–c).
Figure 9 shows the box plots for two different groups used for binary classification.
The box plots were generated by calculating the mean feature values of each group. Five
high-ranked radiomic features extracted from independent and external test sets were
used for comparing the texture differences between benign and malignant and grade 3 and
grade 5 tissue samples. It can be observed that the structure of box plots and the mean
values for each feature in Figure 9a,c are quite similar, which demonstrates that the texture
of prostatic tissue of independent and external test sets was relatively comparable. As a
result, the classification algorithms had a good chance in accurate classification and making
the right decision.
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Figure 9. Comparing the texture differences between beni n and malignant tissue and grade 3 and
grad 5 tissue samples using five high-ranked radiomic features. (a) Box plot comparing the five
high high-ranked radiomic features between benign and malignant (internal test set). (b) Box plot
comparing the five high high-ranked radiomic features between grade 3 and grade 5 (internal test set).
(c) Box plot comparing the five high high-ranked radiomic features between benign and malignant
(external test set).
In our previous study [47], we performed textural analysis and extracted a total of 12
radiomic features (second-order statistic) using the gray-level co-occurrence matrix (GLCM)
method, of which the best 10 features were selected using one-way ANOVA. The image size
was 512 × 512 pixels (24 bits/pixel). Feature classification was performed separately with
10 and 12 features using SVM and K-nearest neighbors (KNN) classification algorithms.
The training-to-testing sample ratio was 8:2. The classification accuracies for SVM were
81.6% and 84.1% using 12 and 10 features, respectively, and the accuracies for KNN were
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77.5% and 79.1% using 12 and 10 features, respectively. In the present study, we used the
window size of 64 × 64 to extract 16 patches from a single image of size 256 × 256 pixels.
The number of data samples for benign and malignant tissues were limited, and, therefore,
patch extraction was performed to boost the training sample per class. The FOS features
were extracted from H&E staining channels after image representation was performed and,
therefore, our AI system uncovered effective results for the detection of PCa. Even though
our proposed H&E network (DC-BiLSTM) achieved high accuracy using the internal test
sets, it did not perform very well for the external test set compared to the Boosting tree
classifier. This is because the proposed network was developed and fine-tuned based on the
private dataset and, in the histological sections, the spatial distributions of an image differed
from one dataset to another. It was difficult to determine the performance of the trained
model using the external or blind test set. However, the proposed network performed well
and achieved satisfactory results according to the hypothesis of this study.
In medical image processing, feature extraction and selection of key features is very
important for microscopic biopsy, magnetic resonance (MR), ultrasound and x-ray image
analyses. However, many researchers use doctors’ recommended clinical features for
disease classification and, therefore, cannot achieve better results. The texture of medical
images provides a lot of information in the spatial arrangement of colors or intensities. A
radiomic method can be used to extract this information for AI-based disease classification,
and thus better diagnostic results can be obtained.
7. Conclusions
We used various FOS features to perform AI-based classification and analyzed textural
dissimilarities in prostate tissue images. The purpose of this paper was to analyze the
significant features and classify them for PCa detection. Two-step feature selection was
effective in terms of selecting important features. Our models yielded promising results
using FOS radiomic features extracted from patch images. We evaluated the performance
and strength of the models using private and public datasets collected from two different
centers. All the AI models achieved high recall in classifying benign and malignant tissue
samples, which is very helpful for researchers and clinicians. Each model was successfully
validated using the two internal and one external test datasets, achieving accuracies of
96.1, 85.2 and 88.2% using SVM; 96.1, 85.1 and 87.9% using LR; 95.6, 80.8 and 91.3% using
Bagging tree; 96.0, 86.0 and 93.5% using Boosting tree and 98.6, 93.6 and 89.2% using
DC-BiLSTM, respectively.
In this study, fine-tuning of the classification models was performed to reduce the
overfitting problem. The performance evaluation of the AI models was carried out using
2 × 2 confusion matrices and ROC curves. Texture analysis of patch-based histopatho-
logical images is sometimes difficult due to spatial changes in image patterns. Therefore,
some preprocessing, like smoothing effect, image normalization and intensity correction, is
necessary to overcome this type of difficulty. However, in this study, gamma correction and
stain deconvolution technique techniques were incorporated to adjust the intensity level
and separate the staining channels of the tissue images, respectively. To analyze the tex-
ture of tissue images and extract significant information, we must use feature-engineered
radiomics techniques. In future studies, it is highly recommended that the validation of
AI models should be performed using other histopathological datasets containing various
cancer cases.
Supplementary Materials: The following are available online at https://www.mdpi.com/2072-669
4/13/7/1524/s1, Figure S1: An example of Bagging Tree classifier. Here, the classification is carried
out in a parallel direction, Figure S2: An example of Boosting Tree classifier. Here, the classification is
performed in a sequential direction, Figure S3: The operation and structure of LSTM cell. Figure S4:
Comparative analysis graphs of four different evaluation metrics that show the results of binary
classification obtained using different AI models. Table S1: The description and formula of the
extracted FOS features.
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